Introduction Healthcare workers are at very high risk for SARS-CoV-2 exposure and infection. This study evaluated anti-SARS-CoV-2 seroprevalence in healthcare workers in a tertiary care hospital and then correlated seroprevalence with confirmed or suspected SARS-CoV-2 infection in this population since the onset of the COVID-19 pandemic. Method The study was approved by our institution’s Joint Research Ethics Committee in June 2020. All volunteers were provided with a consent form, an information leaflet and a questionnaire on the day before phlebotomy. Serum samples were collected from 1176 participants over a 3-month period and analysed using the Elecsys Anti-SARS-CoV-2 assay (Roche Diagnostics GmbH, Mannheim, Germany) which detects total antibodies against the nucleocapsid protein of SARs-COV-2. Results Overall anti-SARS-CoV-2 seroprevalence among participating healthcare workers was 17.9%. The rate of confirmed infection by real-time polymerase chain reaction molecular testing prior to participation was 12.2%. Of 211 participants who had a reactive antibody test result, 37% did not have COVID-19 infection confirmed at any point prior to participation in this study, either having had a swab which did not detect SARS-CoV-2 RNA or having never been tested. Seropositivity was the highest (30%) in the youngest quintile of age (20–29 years old). Staff with more patient contact had a higher seroprevalence of 19.5% compared to 13.4% in staff with less patient contact. Conclusion This study demonstrates that a substantial proportion of SARS-CoV-2 infections in healthcare workers may be asymptomatic or subclinical and thus potentially represent a significant transmission risk to colleagues and patients.
【저자키워드】 SARS-CoV-2, antibody, Seroprevalence, healthcare worker, 【초록키워드】 Healthcare workers, SARS-COV-2 infection, COVID-19 pandemic, hospital, Seroprevalence, Infection, risk, Transmission, anti-SARS-CoV-2, nucleocapsid protein, Research Ethics, polymerase chain reaction, Participation, Asymptomatic, COVID-19 infection, Germany, real-time polymerase chain reaction, Patient, Seropositivity, age, SARS-CoV-2 RNA, Antibody test, Swab, staff, molecular, total antibody, information, Care, questionnaire, SARS-CoV-2 infections, patients, Contact, high risk, test result, Chain Reaction, consent form, serum samples, ethics committee, participant, total antibodies, phlebotomy, Roche Diagnostics, serum sample, Volunteer, reactive, antibody test result, polymerase chain, Result, highest, tested, detect, collected, proportion, evaluated, approved, provided, analysed, less, correlated, Elecsy, 【제목키워드】 hospital, anti-SARS-CoV-2 antibody,